4.3 Article

Radial gradient and radial deviation radiomic features from pre-surgical CT scans are associated with survival among lung adenocarcinoma patients

期刊

ONCOTARGET
卷 8, 期 56, 页码 96013-96026

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.21629

关键词

radiomics; radial gradient; radial deviation; lung adenocarcinoma; quantitative imaging

资金

  1. James & Esther King Biomedical Research Program-Team Science Project [2KT01]
  2. National Cancer Institute (NCI) [U01-CA143062]
  3. NCI Early Detection Research Network [U01-CA200464]
  4. Cancer Center Support Grant (CCSG) at the H. Lee Moffitt Cancer Center and Research Institute
  5. NCI designated Comprehensive Cancer Center [P30-CA76292]

向作者/读者索取更多资源

The goal of this study was to extract features from radial deviation and radial gradient maps which were derived from thoracic CT scans of patients diagnosed with lung adenocarcinoma and assess whether these features are associated with overall survival. We used two independent cohorts from different institutions for training (n= 61) and test (n= 47) and focused our analyses on features that were non-redundant and highly reproducible. To reduce the number of features and covariates into a single parsimonious model, a backward elimination approach was applied. Out of 48 features that were extracted, 31 were eliminated because they were not reproducible or were redundant. We considered 17 features for statistical analysis and identified a final model containing the two most highly informative features that were associated with lung cancer survival. One of the two features, radial deviation outside-border separation standard deviation, was replicated in a test cohort exhibiting a statistically significant association with lung cancer survival (multivariable hazard ratio = 0.40; 95% confidence interval 0.17-0.97). Additionally, we explored the biological underpinnings of these features and found radial gradient and radial deviation image features were significantly associated with semantic radiological features.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Engineering, Biomedical

Robust whole-tumour 3D volumetric CT-based radiomics approach for predicting the WHO/ISUP grade of a ccRCC tumour

Ahmet Karagoz, Albert Guvenis

Summary: This study aimed to improve the discrimination power of clearing cell renal cell carcinoma (ccRCC) tumor grades using three-dimensional radiomic features and ensemble learning models. The results showed that the proposed model achieved high reliability in predicting the tumor grade from 3D CT images, despite the limited dataset. The algorithm demonstrated moderate robustness against segmentation deviations by observers, while features from the peritumour area did not significantly improve the results.

COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING-IMAGING AND VISUALIZATION (2023)

Editorial Material Oncology

ASO Visual Abstract: Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis

Jaileene Perez-Morales, Kristy K. Broman, Deepti Bettampadi, Mary Katherine Haver, Jonathan S. Zager, Matthew B. Schabath

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis

Jaileene Perez-Morales, Kristy K. Broman, Deepti Bettampadi, Mary Katherine Haver, Jonathan S. Zager, Matthew B. Schabath

Summary: This systematic review aims to examine the timing and patterns of recurrence for patients with regionally metastatic melanoma based on nodal management and adjuvant therapy. The study found that adjuvant treatment improved recurrence-free survival (RFS), but did not alter the patterns of recurrence. Future studies should report the specific sites of disease recurrence based on adjuvant systemic treatment and surveillance practices to provide better advice to patients about their recurrence patterns and risks.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium

Miguel Garcia-Pardo, Amy Chang, Sabine Schmid, Mei Dong, M. Catherinen Brown, David Christiani, Hilary Aurora Tindel, Paul Brennan, Chu Chen, Jie Zhang, Brid M. Ryan, David Zaridze, Matthew B. Schabath, Leticia Ferro Leal, Rui Manuel Reis, Adonina Tardon, Guillermo Fernandez-Tardon, Sanjay S. Shete, Angeline Andrew, Hermann Brenner, Wei Xu, Rayjean J. Hung, Geoffrey Liu

Summary: This study examined the association between respiratory and cardiometabolic comorbidities and overall survival (OS) and lung cancer-specific survival (LCSS) in non-small cell lung cancer (NSCLC) patients. The analysis showed that NSCLC patients with respiratory comorbidities had worse LCSS, while those with cardiometabolic comorbidities had a higher risk of death from competing causes. Patients with respiratory comorbidities were also less likely to undergo surgical resection.

JOURNAL OF THORACIC ONCOLOGY (2023)

Review Oncology

Criteria for the translation of radiomics into clinically useful tests

Erich P. Huang, James P. B. O'Connor, Lisa M. McShane, Maryellen L. Giger, Philippe Lambin, Paul E. Kinahan, Eliot L. Siegel, Lalitha K. Shankar

Summary: Integration of computer-extracted tumour characteristics into medical imaging computer-aided diagnosis (CAD) algorithms has been a long-standing practice. However, the translation of radiomics, an extension of CAD involving quantitative characterization of healthy or pathological structures and processes captured by medical imaging, into clinically useful tools has been limited. This may be due to factors such as varying imaging and radiomic feature extraction protocols, potential pitfalls in radiomic data analysis, and a lack of evidence demonstrating the clinical benefit of radiomic-based tools. The authors provide 16 criteria to guide the clinical translation of radiomics, with the aim of accelerating the use of this technology to improve patient outcomes.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Article Oncology

Deep learning based identification of bone scintigraphies containing metastatic bone disease foci

Abdalla Ibrahim, Akshayaa Vaidyanathan, Sergey Primakov, Flore Belmans, Fabio Bottari, Turkey Refaee, Pierre Lovinfosse, Alexandre Jadoul, Celine Derwael, Fabian Hertel, Henry C. C. Woodruff, Helle D. D. Zacho, Sean Walsh, Wim Vos, Mariaelena Occhipinti, Francois-Xavier Hanin, Philippe Lambin, Felix M. M. Mottaghy, Roland Hustinx

Summary: The study aims to develop a deep learning (DL) algorithm for classifying areas of increased uptake on bone scintigraphy scans. The algorithm was trained and validated on a dataset of 2365 scans, and its performance was evaluated on an external testing set of 998 scans. The results showed that the DL algorithm achieved higher specificity and sensitivity compared to nuclear medicine physicians, and it can detect metastatic bone disease (MBD) in a shorter time.

CANCER IMAGING (2023)

Article Oncology

Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes

Audrey R. Freischel, Jamie K. Teer, Kimberly Luddy, Jessica Cunningham, Yael Artzy-Randrup, Tamir Epstein, Kenneth Y. Tsai, Anders Berglund, John L. Cleveland, Robert J. Gillies, Joel S. Brown, Robert A. Gatenby

Summary: Evolution plays a crucial role in the initiation and progression of cancer. In addition to driver mutations, natural selection conserves genes that are necessary for optimal cancer cell fitness. By studying subtypes of lung adenocarcinoma, we identified highly mutated and highly conserved genes, which have common utility in adapting to similar tissue environments and are critical for optimal fitness. Targeting tumor-specific conserved genes may represent an effective treatment strategy.

CANCERS (2023)

Article Oncology

Qualitative Findings From a Survey on Patient Experiences and Satisfaction with Lung Cancer Screening

Jaileene Perez-Morales, Rashmi Pathak, Monica Reyes, Haley Tolbert, Rajwantee Tirbene, Jhanelle E. Gray, Vani N. Simmons, Matthew B. Schabath, Gwendolyn P. Quinn

Summary: In order to evaluate the lung cancer screening program, a survey was conducted to measure patient experiences and satisfaction. Results showed that patients generally had positive comments, but also expressed concerns about the lack of information, long wait times, and billing issues. Suggestions for improvement included online appointments, reminders, lower costs, and clarification of eligibility criteria.

CANCER CONTROL (2023)

Review Oncology

Cancer in Transgender and Gender-Diverse Persons A Review

Alberto Giovanni Leone, Dario Trapani, Matthew B. Schabath, Joshua D. Safer, N. F. N. Scout, Matteo Lambertini, Rossana Berardi, Silvia Marsoni, Francesco Perrone, Saverio Cinieri, Rosalba Miceli, Federica Morano, Filippo Pietrantonio

Summary: Transgender and gender-diverse individuals face unique challenges in cancer risk and outcomes due to barriers to health care access and inequities in treatment. Research shows a high prevalence of tobacco consumption, alcohol use, HPV and HIV infections among this population. These individuals are less likely to adhere to cancer screening programs and have a higher incidence of HIV- and HPV-associated cancers. A lack of knowledge among health care practitioners about the health needs of gender minorities and other barriers further hinder cancer prevention, care, and survivorship for transgender and gender-diverse individuals.

JAMA ONCOLOGY (2023)

Article Oncology

From Head and Neck Tumour and Lymph Node Segmentation to Survival Prediction on PET/CT: An End-to-End Framework Featuring Uncertainty, Fairness, and Multi-Region Multi-Modal Radiomics

Zohaib Salahuddin, Yi Chen, Xian Zhong, Henry C. Woodruff, Nastaran Mohammadian Rad, Shruti Atul Mali, Philippe Lambin

Summary: Automatic delineation and detection of primary tumour (GTVp) and lymph nodes (GTVn) in head and neck cancer using PET and CT can help diagnose and stratify patient risk. This study utilized data from nine centres and developed a segmentation model that estimated uncertainty for false positive reduction. Radiomics features extracted from GTVp and GTVn in PET and CT were found to be prognostic for recurrence-free survival prediction. The framework incorporated uncertainty estimation, fairness, and explainability.

CANCERS (2023)

Article Oncology

Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning

Ryan Fogarty, Dmitry Goldgof, Lawrence Hall, Alex Lopez, Joseph Johnson, Manoj Gadara, Radka Stoyanova, Sanoj Punnen, Alan Pollack, Julio Pow-Sang, Yoganand Balagurunathan

Summary: In recent years, Gleason's prostate cancer histopathological description has become a universal standard for disease diagnosis and progression. We have developed deep learning models to assist clinicians in identifying the primary cancer grade. These models have significant application value in histopathological classification.

CANCERS (2023)

Article Oncology

Cancer survivors' health behaviors and outcomes: a population-based study of sexual and gender minorities

Ulrike Boehmer, Shine Chang, Nelson F. Sanchez, Bill M. Jesdale, Matthew B. Schabath

Summary: This study compared health risk behaviors and outcomes between sexual and gender minority cancer survivors and matched controls. The findings showed that sexual and gender minority cancer survivors face higher risks in terms of mental health, physical health, and health behaviors, indicating the urgent need for preventive measures.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Interpretable radiomics method for predicting human papillomavirus status in oropharyngeal cancer using Bayesian networks

Oya Altinok, Albert Guvenis

Summary: This study developed a simple and interpretable Bayesian Network (BN) model to classify HPV status in patients with oropharyngeal cancer. The model selected two relevant predictors from patients' CT images and demonstrated good performance in predicting HPV positivity. The BN model's straightforward structure and interpretability make it useful for clinicians in treatment decision-making and non-invasive detection of HPV status.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2023)

Article Oncology

Protocol optimization of a targeted sequencing panel for genomic profiling of bronchoalveolar lavage fluid in lung cancer

Cassandra L. Sather, Pamela Yang, Chaomei Zhang, Matthew P. Fitzgibbon, Michelle Fournier, Eric Toloza, Amit Tandon, Matthew Schabath, Sean Yoder, Viswam S. Nair

Summary: We investigated the impact of sequencing depth, variant calling strategy, and targeted sequencing region on identifying tumor-derived variants in cell-free bronchoalveolar lavage (cfBAL) DNA compared with plasma cfDNA. Low-coverage sequencing detected tumor-derived cfBAL variants in a higher percentage of patients compared to plasma, and high-coverage sequencing did not affect the number of tumor-derived variants detected in either biospecimen type. Accounting for germline mutations eliminated false-positive plasma calls and increased the number of cfBAL calls, irrespective of coverage and the number of targeted genes.

CANCER MEDICINE (2023)

Article Oncology

An Interpretable Radiomics Model Based on Two-Dimensional Shear Wave Elastography for Predicting Symptomatic Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma

Xian Zhong, Zohaib Salahuddin, Yi Chen, Henry C. Woodruff, Haiyi Long, Jianyun Peng, Xiaoyan Xie, Manxia Lin, Philippe Lambin

Summary: This study developed and validated an interpretable radiomics model based on two-dimensional shear wave elastography (2D-SWE) for predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma. The clinical-radiomics model outperformed the clinical model and radiomics model, and the first-order radiomics features were identified as the most important for PHLF prediction.

CANCERS (2023)

暂无数据